234 related articles for article (PubMed ID: 31473076)
1. Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy.
Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
HPB (Oxford); 2020 Mar; 22(3):461-469. PubMed ID: 31473076
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma: Long-term outcomes and prognostic factors.
Ryu T; Takami Y; Wada Y; Sasaki S; Imamura H; Ureshino H; Saitsu H
Asian J Surg; 2021 Jan; 44(1):186-191. PubMed ID: 32473893
[TBL] [Abstract][Full Text] [Related]
4. Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan.
Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
Ann Surg Oncol; 2019 Nov; 26(12):4126-4133. PubMed ID: 31359277
[TBL] [Abstract][Full Text] [Related]
5. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
[TBL] [Abstract][Full Text] [Related]
6. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
7. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
8. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
Meniconi RL; Komatsu S; Perdigao F; Boëlle PY; Soubrane O; Scatton O
Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
10. Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation and/or Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Einama T; Kamachi H; Taketomi A
Dig Surg; 2018; 35(5):427-434. PubMed ID: 28903105
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.
Matsuda M; Fujii H; Kono H; Matsumoto Y
J Hepatobiliary Pancreat Surg; 2001; 8(4):353-9. PubMed ID: 11521181
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma.
Ueno M; Uchiyama K; Ozawa S; Nakase T; Togo N; Hayami S; Yamaue H
Surg Today; 2009; 39(8):675-81. PubMed ID: 19639434
[TBL] [Abstract][Full Text] [Related]
14. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox.
Ei S; Hibi T; Tanabe M; Itano O; Shinoda M; Kitago M; Abe Y; Yagi H; Okabayashi K; Sugiyama D; Wakabayashi G; Kitagawa Y
Ann Surg Oncol; 2015 Apr; 22(4):1294-300. PubMed ID: 25287439
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
[No Abstract] [Full Text] [Related]
16. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
17. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
18. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and safety of surgical microwave ablation for hepatocellular carcinoma in elderly patients: a single center analysis in Japan.
Imamura H; Takami Y; Ryu T; Wada Y; Sasaki S; Ureshino H; Saitsu H
Sci Rep; 2020 Aug; 10(1):14215. PubMed ID: 32848193
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.
Wang Y; Liao Y; Liu W; Zhang Y; Yuan Y; Qiu Y; Qiu J; Yang Z; He W; Wang C; Li K; Shi Y; Zuo D; Yuan Y; Li B
Dig Surg; 2021; 38(1):46-57. PubMed ID: 33152739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
